Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Curious about what you can buy with credit card points? Explore a variety of exciting options to make the most of your rewards!
28,188 articlesBarclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Bank of America raises Coherent's price target to $400 on a larger AI data center market forecast, keeping a Neutral ...
As Trump claims credit for the market surge, data shows Nvidia-led momentum dominates the gains and market breadth re...
Tokenized treasuries moving onto the XRP Ledger are expanding rapidly, with massive on-chain volumes and a key JPMorg...
Carnival sailed to another quarter of record yields, yet its shares lag Royal Caribbean as debt, pricing power, and c...
A $28 billion AI hardware IPO is trading at about 7x forward earnings, sparking a heated debate: is it a disrupted, d...
AXT Inc. is poised for a pivotal earnings night after a dramatic rally. Look for updates on demand for indium phosphi...
A noted tech investor forecasts AI could automate most jobs by 2030. This report explores how families might keep ess...
Scotiabank boosted Cameco's price target to $175 as a global push for nuclear power gains traction and a new supply d...
Bitcoin faced a sharp test as ETF-related outflows spiked, pushing BTC toward important support levels. Traders are w...
Bitcoin edges toward the long-term holder cost basis as on-chain data flags growing risk of capitulation. Analysts wa...
Pi Network rolls out major upgrades and a second migration as Kraken opens Pi trading, driving volatility amid Pi Day...